Mood Disorders (Mood Disorder)

Those disorders that have a disturbance in mood as their predominant feature.
Also Known As:
Mood Disorder; Affective Disorders; Affective Disorder; Disorders, Mood; Disorder, Mood; Disorder, Affective; Disorders, Affective
Networked: 10942 relevant articles (604 outcomes, 1604 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Schizophrenia (Dementia Praecox)
2. Bipolar Disorder (Manic Depressive Psychosis)
3. Epilepsy (Aura)
4. Mood Disorders (Mood Disorder)
5. Mania (Manias)


1. McIntyre, Roger S: 57 articles (01/2022 - 02/2006)
2. Serretti, Alessandro: 52 articles (01/2022 - 01/2002)
3. Zarate, Carlos A: 47 articles (01/2022 - 01/2002)
4. Berk, Michael: 38 articles (06/2022 - 06/2006)
5. Vinberg, Maj: 38 articles (01/2021 - 04/2007)
6. Maes, Michael: 33 articles (08/2022 - 11/2003)
7. Young, Allan H: 32 articles (01/2022 - 09/2002)
8. Manji, Husseini K: 31 articles (01/2022 - 01/2002)
9. Kessing, Lars Vedel: 30 articles (01/2021 - 08/2006)
10. Rybakowski, Janusz K: 28 articles (01/2022 - 05/2003)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Mood Disorders:
1. LithiumIBA
2. Antidepressive Agents (Antidepressants)IBA
3. Pharmaceutical PreparationsIBA
4. Antipsychotic Agents (Antipsychotics)IBA
5. Anticonvulsants (Antiepileptic Drugs)IBA
6. Carbamazepine (Tegretol)FDA LinkGeneric
7. Serotonin (5 Hydroxytryptamine)IBA
8. KetamineFDA LinkGeneric
01/01/2023 - "Limitations, clinical considerations, and opportunities for future research include the following points: large placebo effects when studying suicidal ideation reduction; small concerns about blinding quality due to dissociative effects; no studies on the risk/prevention of suicidal acts and mortality; lack of studies beyond affective disorders; no studies in adolescents and older people; lack of knowledge of long-term side effects, notably liability for abuse; no robust predictive markers; limited understanding of the mechanisms of ketamine on suicidal ideas; need for improved assessment of suicidal ideation in clinical trials; need for studies in outpatient settings, emergency room, and liaison consultation; need for research on ketamine administration; limited knowledge on the positive and negative effects of concomitant treatments. "
01/01/2022 - "Despite strong evidence for the safety and efficacy of ketamine in the treatment of mood disorders, the enrollment of Black, Indigenous, and People of Color (BIPOC) has not been a focus of this research. "
12/01/2020 - "Our preliminary results suggest that IV ketamine is effective in rapidly treating AIA and SI in adults with treatment-resistant mood disorders. "
06/01/2016 - "Third, is ketamine only effective in reducing suicidal ideation in patients with mood disorders? "
10/01/2023 - "Therefore, while ketamine may be a promising treatment for various mood disorders, caution should be exercised when using ketamine to treat disorders associated with early life stress. "
9. Biological ProductsIBA
10. Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA

Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Phototherapy (Light Therapy)
4. Transcranial Magnetic Stimulation
5. Aftercare (After-Treatment)